This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
QIAGEN (QGEN) QCI's Robust Adoption to Enhance Patient Outcome
by Zacks Equity Research
QIAGEN's (QGEN) QCI platform is expected to significantly streamline NGS data analysis and variant interpretation, and enable swift and confident shift by users from raw NGS data to clinical report.
3 Medical Device Stocks With Potential to Fight Recession Risk
by Indrajit Bandyopadhyay
The decline in U.S. GDP during the first quarter and 26% decline in the S&P 500 Index so far this year fuel the risk of a recession. MCK, PDCO & AMN have the potential to help investors ward off volatility risks going forward.
NextGen (NXGN)-InstaMed Ink Deal to Improve Payment Processing
by Zacks Equity Research
NextGen's (NXGN) latest expanded deal with InstaMed is expected to significantly simplify payment methods for both patients and providers.
3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio
by Zacks Equity Research
Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care.
Reasons to Retain Surmodics (SRDX) Stock in Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about Surmodics (SRDX) owing to its solid prospects in the thrombectomy business.
Alcon's (ALC) Product Launches, Market Recovery Aid Growth
by Zacks Equity Research
Despite bearing the brunt of inflationary pressure across both Total Surgical and Vision Care franchises, Alcon (ALC) succeeds in mitigating much of the impact through cost-improvement efforts.
McKesson (MCK) Gains But Lags Market: What You Should Know
by Zacks Equity Research
McKesson (MCK) closed at $330 in the latest trading session, marking a +1.08% move from the prior day.
3 Reasons Why BD (BDX) is a Great Pick For Your Portfolio Now
by Zacks Equity Research
Investors continue to be optimistic about BD (BDX) owing to a few regulatory approvals and strategic deals.
Has McKesson (MCK) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how McKesson (MCK) and Immunocore Holdings PLC Sponsored ADR (IMCR) have performed compared to their sector so far this year.
Zacks Value Trader Highlights: H&R Block, McKesson, Stride, TransAlta and Murphy USA
by Zacks Equity Research
H&R Block, McKesson, Stride, TransAlta and Murphy USA are part of Zacks Value Trader blog.
5 Value Stocks Near Their 52-Week Highs
by Tracey Ryniec
Not every stock is selling off in 2022. Here are 5 cheap stocks with high Zacks Rank trading near their 52-week highs.
This Medical Supplier Is Pushing All-Time Highs
by Derek Lewis
McKesson shares have been scorching-hot year-to-date, increasing by more than 30% in value and extensively outperforming both its Zacks Sector and the S&P 500.
McKesson (MCK) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, McKesson (MCK) closed at $325.18, marking a -0.67% move from the previous day.
McKesson (MCK) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does McKesson (MCK) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is McKesson (MCK) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's How Much a $1000 Investment in McKesson Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
McKesson (MCK) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
McKesson (MCK) closed the most recent trading day at $321.25, moving -0.09% from the previous trading session.
Here's Why You Should Retain McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
Should IQ Chaikin U.S. Large Cap ETF (CLRG) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for CLRG
McKesson (MCK) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, McKesson (MCK) closed at $329.53, marking a +1.02% move from the previous day.
McKesson (MCK) Stock Moves -0.56%: What You Should Know
by Zacks Equity Research
McKesson (MCK) closed at $326.21 in the latest trading session, marking a -0.56% move from the prior day.
Is IQ Chaikin U.S. Large Cap ETF (CLRG) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for CLRG
Zacks.com featured highlights include American Airlines, PBF Energy, McKesson, Commercial Metals, AmericanAxle & Manufacturing
by Zacks Equity Research
American Airlines, PBF Energy, McKesson, Commercial Metals, AmericanAxle & Manufacturing are part of Screen of the Week article.
HCA Healthcare (HCA) Boosts Cancer Portfolio With McKesson JV
by Zacks Equity Research
HCA Healthcare (HCA) inks a joint venture with McKesson to strengthen the cancer offerings suite of both partners. The move will offer HCA the chance to capitalize on the growing cancer therapeutics market.
5 Stocks to Seek Refuge in Amid Current Market Bloodbath
by Maharathi Basu
For significant returns, investors should keep broker-friendly stocks like American Airlines (AAL), PBF Energy (PBF), McKesson Corporation (MCK), Commercial Metals (CMC) and American Axle (AXL) on their radar.